Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Najjar

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Molecular Metabolism|February 4, 2018
Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 geneLucia Russo, Harrison T Muturi, Hilda E Ghadieh, et al.
Journal of Lipid Research|October 26, 2016
Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axisLucia Russo, Hilda E Ghadieh, Simona S Ghanem, et al.
Frontiers in Endocrinology|April 12, 2017
Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in ObesityGarrett Heinrich, Harrison T Muturi, Khadijeh Rezaei, et al.
Diabetes|June 12, 2008
Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolismAnthony M DeAngelis, Garrett Heinrich, Tong Dai, et al.
Cardiovascular Research|December 3, 2008
Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacityPer Magnus Haram, Ole J Kemi, Sang Jun Lee, et al.
Metabolism: Clinical and Experimental|August 12, 2018
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in micePablo Villa-Pérez, Beatriz Merino, Cristina M Fernández-Díaz, et al.
The Journal of Clinical Investigation|July 13, 2011
Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetesJoseph P Tiano, Viviane Delghingaro-Augusto, Cedric Le May, et al.
Experimental Diabesity Research|October 30, 2004
Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strainMarcia F McInerney, Sonia M Najjar, Deanna Brickley, et al.
Frontiers in Endocrinology|August 19, 2015
Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose TissueSumona G Lester, Lucia Russo, Simona S Ghanem, et al.
Hepatology Communications|February 7, 2018
Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosisHilda E Ghadieh, Harrison T Muturi, Lucia Russo, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Molecular Metabolism|February 4, 2018
Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 geneLucia Russo, Harrison T Muturi, Hilda E Ghadieh, et al.
Journal of Lipid Research|October 26, 2016
Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axisLucia Russo, Hilda E Ghadieh, Simona S Ghanem, et al.
Frontiers in Endocrinology|April 12, 2017
Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in ObesityGarrett Heinrich, Harrison T Muturi, Khadijeh Rezaei, et al.
Diabetes|June 12, 2008
Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolismAnthony M DeAngelis, Garrett Heinrich, Tong Dai, et al.
Cardiovascular Research|December 3, 2008
Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacityPer Magnus Haram, Ole J Kemi, Sang Jun Lee, et al.
Metabolism: Clinical and Experimental|August 12, 2018
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in micePablo Villa-Pérez, Beatriz Merino, Cristina M Fernández-Díaz, et al.
The Journal of Clinical Investigation|July 13, 2011
Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetesJoseph P Tiano, Viviane Delghingaro-Augusto, Cedric Le May, et al.
Experimental Diabesity Research|October 30, 2004
Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strainMarcia F McInerney, Sonia M Najjar, Deanna Brickley, et al.
Frontiers in Endocrinology|August 19, 2015
Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose TissueSumona G Lester, Lucia Russo, Simona S Ghanem, et al.
Hepatology Communications|February 7, 2018
Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosisHilda E Ghadieh, Harrison T Muturi, Lucia Russo, et al.
Pageof 19